BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hao Q, Wu Y, Wu Y, Wang P, Vadgama JV. Tumor-Derived Exosomes in Tumor-Induced Immune Suppression. Int J Mol Sci 2022;23:1461. [PMID: 35163380 DOI: 10.3390/ijms23031461] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Yao M, Liang S, Cheng B. Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine. Front Pharmacol 2023;14. [DOI: 10.3389/fphar.2023.1110922] [Reference Citation Analysis]
2 Pitzer CR, Paez HG, Alway SE. The Contribution of Tumor Derived Exosomes to Cancer Cachexia. Cells 2023;12. [PMID: 36672227 DOI: 10.3390/cells12020292] [Reference Citation Analysis]
3 Najaflou M, Shahgolzari M, Khosroushahi AY, Fiering S. Tumor-Derived Extracellular Vesicles in Cancer Immunoediting and Their Potential as Oncoimmunotherapeutics. Cancers (Basel) 2022;15. [PMID: 36612080 DOI: 10.3390/cancers15010082] [Reference Citation Analysis]
4 Reale A, Khong T, Spencer A. Extracellular Vesicles and Their Roles in the Tumor Immune Microenvironment. J Clin Med 2022;11. [PMID: 36498469 DOI: 10.3390/jcm11236892] [Reference Citation Analysis]
5 Xiong Y, Mi B, Lin Z, Hu Y, Yu L, Zha K, Panayi AC, Yu T, Chen L, Liu Z, Patel A, Feng Q, Zhou S, Liu G. The role of the immune microenvironment in bone, cartilage, and soft tissue regeneration: from mechanism to therapeutic opportunity. Military Med Res 2022;9:65. [DOI: 10.1186/s40779-022-00426-8] [Reference Citation Analysis]
6 Heo CK, Lim WH, Park I, Choi YS, Lim KJ, Cho EW. Serum BRD2 autoantibody in hepatocellular carcinoma and its detection using mimotope peptide‑conjugated BSA. Int J Oncol 2022;61:158. [PMID: 36321789 DOI: 10.3892/ijo.2022.5448] [Reference Citation Analysis]
7 Matsuzaka Y, Yashiro R. Molecular Docking and Intracellular Translocation of Extracellular Vesicles for Efficient Drug Delivery. IJMS 2022;23:12971. [DOI: 10.3390/ijms232112971] [Reference Citation Analysis]
8 Li Y, Chen Z, Duan X, Zhang H, Xiao B, Wang K, Chen G. Targeted inhibition of tumor-derived exosomes as a novel therapeutic option for cancer. Exp Mol Med. [DOI: 10.1038/s12276-022-00856-3] [Reference Citation Analysis]
9 Rasihashemi SZ, Sahrai H, Rezazadeh-Gavgani E, Yazdani Y, Khalaji A, Lotfinejad P. Exosomes carrying immune checkpoints, a promising therapeutic approach in cancer treatment. Med Oncol 2022;39:183. [PMID: 36071295 DOI: 10.1007/s12032-022-01781-1] [Reference Citation Analysis]
10 Fanale D, Dimino A, Pedone E, Brando C, Corsini LR, Filorizzo C, Fiorino A, Lisanti MC, Magrin L, Randazzo U, Bazan Russo TD, Russo A, Bazan V. Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer. Cancers 2022;14:4344. [DOI: 10.3390/cancers14184344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Buzas EI. The roles of extracellular vesicles in the immune system. Nat Rev Immunol 2022. [PMID: 35927511 DOI: 10.1038/s41577-022-00763-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
12 Li Y, Gao S, Hu Q, Wu F. Functional Properties of Cancer Epithelium and Stroma-Derived Exosomes in Head and Neck Squamous Cell Carcinoma. Life 2022;12:757. [DOI: 10.3390/life12050757] [Reference Citation Analysis]